Study: Spike in the price of gout drug colchicine linked to lower use and worse disease control
Can't see this email? View it online
   
  Gout  
  Gout news alert from News Medical  
 Gout unveiled as surprising culprit in neurodegenerative diseasesGout unveiled as surprising culprit in neurodegenerative diseases
 
Research highlights the association between gout and neurodegenerative diseases, revealing that gout patients exhibit smaller brain volumes, increased brain iron markers, and a higher incidence of conditions such as dementia, Parkinson's disease, and essential tremor, particularly within the first three years after diagnosis.
 
 
 Study: Spike in the price of gout drug colchicine linked to lower use and worse disease controlStudy: Spike in the price of gout drug colchicine linked to lower use and worse disease control
 
Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly 16-fold from $11.25 in 2009 to $190.49 in 2011.
 
 Colchicine therapy benefits pediatric long COVID patients suffering from recurring fever
 
Colchicine therapy benefits pediatric long COVID patients suffering from recurring feverResearchers at National Jewish Health found that a subset of children suffering recurring fevers as a result of long COVID-19, benefited from a daily medication treatment commonly used for gout and periodic fever syndrome.
 
 
 Weekend catch-up sleep may minimize the risk of hyperuricemia in postmenopausal women
 
Weekend catch-up sleep may minimize the risk of hyperuricemia in postmenopausal womenSleep deprivation, especially common during postmenopause, has been linked with a number of health problems, including hyperuricemia (elevated serum uric acid), which can often lead to gout and other life-threatening conditions such as heart disease.